Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with platinum-based chemotherapy in advanced NSCLC
NCT00828841Phase 2Completed
- Sponsor
- Accelerated Community Oncology Research Network
- Start
- Dec 2008
- Primary completion
- Jul 2012
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in non-small cell lung cancer (NSCLC), sponsored by Accelerated Community Oncology Research Network. Started Dec 2008; status: completed.
02
Drugs
cetuximab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00828841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828841.